ArticleFrontiers in oncology2023

Neoadjuvant chemoimmunotherapy cycle number selection for non-small cell lung cancer and clinical outcomes: a real-world analysis.

Baihua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.